TROP2 is highly expressed in several cancers and may play a critical role in tumor progression in association with the pathways involving both the extracellular signal-related kinase (ERK) and c-Jun N-terminal kinase (JNK) (12,13). This evidence concerns the gene TACSTD2 and neoplasm.